Investment
Features
FeesSafety
Academy
More
Pluang+

Bank of America predicts Oracle stock will surge over 80% in the next year despite recent setbacks.

Analyst Insights
20 Oct 2026
Finbold
View Source
Bullish
Bank of America predicts Oracle stock will surge over 80% in the next year despite recent setbacks.

Bank of America reaffirmed its bullish outlook on Oracle, rating the stock as a 'Buy' with a target price of $240, an 80.83% increase from its current price of $132.72. This prediction comes despite Oracle's recent 35.51% price drop since June, credit rating downgrade to BBB-, and a force majeure notice for its New Mexico data center. The bank highlights Oracle's $50 billion equity and debt raises and strong software sector as key positives. Overall, Wall Street remains optimistic with an average target price of $249.11 and mostly positive analyst ratings, though some recent revisions have been more cautious.

Following Bank of America's bullish outlook on Oracle, the stock is trading at USD 133.42 on Pluang as of Oct 20, 2026 22:03 WIB, showing a 1-day gain of 2.92%. Oracle's market cap stands at $392.85 billion, with a dividend yield of 1.54%. Investor sentiment on Pluang remains positive, with 90% of orders to buy and a typical hold time of 74 days.

More News (ORCL)

CoreWeave shares drop 4% as HSBC warns of debt risks amid rising borrowing costs.

CoreWeave shares drop 4% as HSBC warns of debt risks amid rising borrowing costs.

CoreWeave's stock fell 4% following HSBC's reiteration of a bearish rating due to concerns over the company's heavy reliance on debt financing and rising borrowing costs. Rival Nebius also dropped 5%, reflecting broader pressure on debt-funded AI clo...

Market News
Bearish
6 hours ago
Oracle to pay unchanged $0.5 quarterly dividend on Oct 23, 2026, rewarding shareholders steadily.

Oracle to pay unchanged $0.5 quarterly dividend on Oct 23, 2026, rewarding shareholders steadily.

Oracle will pay its final quarterly dividend of 2026 on October 23, 2026, at $0.5 per share, unchanged from previous quarters. Shareholders who owned the stock before the ex-dividend date of October 9 are eligible for this payout. The dividend yield ...

Company Fundamentals
Neutral
11 hours ago
Oracle and AstraZeneca team up to use AI and real-world data to speed up clinical trials and improve patient care.

Oracle and AstraZeneca team up to use AI and real-world data to speed up clinical trials and improve patient care.

Oracle and AstraZeneca have entered a collaboration to combine AstraZeneca's scientific expertise with Oracle's AI, cloud, and real-world data capabilities. The partnership aims to accelerate clinical trials by helping clinicians identify eligible pa...

Market News
Bullish
14 hours ago
Oracle's cloud revenue soars but stock lags, signaling 50% upside potential for investors.

Oracle's cloud revenue soars but stock lags, signaling 50% upside potential for investors.

Oracle's cloud infrastructure revenue more than doubled last quarter, yet its stock price has dropped over 30% this year due to concerns about debt and capital spending. Despite this, Oracle beat revenue and earnings estimates, and raised its fiscal ...

Analyst Insights
Bullish
1 day ago
CoreWeave jumps 6% after Goldman Sachs upgrades its stock amid debt concerns.

CoreWeave jumps 6% after Goldman Sachs upgrades its stock amid debt concerns.

Goldman Sachs upgraded CoreWeave from Neutral to Buy, boosting its stock by 6%. The upgrade comes after a selloff driven by concerns over CoreWeave's heavy debt used to fund its AI-focused data center expansion. Despite debt worries, CoreWeave's oper...

Market News
Bullish
1 day ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App